La Jolla Institute receives $5 million gift from Pfizer
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) has received a $5 million gift, which will help establish the Mission
Dr. Mitchell Kronenberg named “Most Admired CEO” by the San Diego Business Journal
LA JOLLA, CA—The La Jolla Institute for Immunology is proud to announce that Mitchell Kronenberg, Ph.D., the President and Chief
Three top leaders from varied fields join La Jolla Institute board of directors
LA JOLLA, CA – The La Jolla Institute for Immunology (LJI) is pleased to announce that three leaders from the
La Jolla Institute scientist identifies pivotal cellular protein underlying eczema
SAN DIEGO – January 9, 2014 Researchers from the La Jolla Institute for Immunology have revealed a critical player in
Three San Diego executives elected to La Jolla Institute board of directors
The new members are: Sergio Jinich, a distinguished real estate and construction executive in the U.S. and Mexico; Tina Nova,
La Jolla Institute scientist named World’s #1 Expert in Juvenile Diabetes
Type 1 diabetes is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables one
La Jolla Institute develops new approach to identify genes poised to respond in asthma patients
SAN DIEGO – July 8, 2014 In a study published yesterday in the scientific journal Nature Immunology, a group at
La Jolla Institute scientist recieves $1.6 million research grant from American Diabetes Association
SAN DIEGO – January 8, 2015 The American Diabetes Association (ADA) has awarded La Jolla Institute (LJI) researcher Stephanie Stanford,
The company you keep
LA JOLLA, CA – February 12, 2015 When fighting chronic viral infections or cancers, a key division of the immune
La Jolla Institute scientists reveal potential new drug target for the treatment of rheumatoid arthritis
Researchers at the La Jolla Institute for Immunology, in collaboration with colleagues the University of California, San Diego, identified a